
Citcopace P 500mg/800mg Tablet
Marketer
Leeford Healthcare Ltd
Salt Composition
Citicoline (500mg) + Piracetam (800mg)
Overview Citcopace P 500mg/800mg Tablet
NeuroMend 500mg/800mg tablets are prescribed to aid stroke recovery and enhance cognitive function. This medication safeguards brain cells from harm and facilitates their repair, also finding application in treating brain injuries. NeuroMend can be ingested with or without food, ideally at the same consistent time daily to ensure uniform blood levels. Adhere to your physician's prescribed dosage and regimen; if a dose is missed, take it immediately upon recollection. Complete the entire course, even with symptom improvement, and never discontinue use abruptly without consulting your doctor, as this could exacerbate your condition. Potential side effects, such as heightened activity, abdominal discomfort, anxiety, and low blood pressure, are generally transient and self-limiting. Consult your doctor if these persist or are troubling. Maintain adequate hydration by drinking plenty of fluids, especially as diarrhea can occur. Weight gain is possible; mitigate this with a balanced diet and regular exercise.
Uses of Citcopace P 500mg/800mg Tablet
Stroke Recovery Program
Major Benefits of Citcopace P 500mg/800mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Citcopace P 500mg/800mg tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency is key—take it at the same time each day.
Common Side effects of Citcopace P 500mg/800mg Tablet:
- Weight gain
- Hyperactivity
- Stomach pain
- Nervousness
- Diarrhea
- Decreased blood pressure
- Uncoordinated body movements
- Dizziness
How to use Citcopace P 500mg/800mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Citcopace P 500mg/800mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. While you can take them with or without food, consistent timing is recommended for optimal results.
How Citcopace P 500mg/800mg Tablet works:
Combipac 500mg/800mg tablets contain citicoline and piracetam, offering neuroprotective benefits. Citicoline, a neurotrophic agent, supports neuronal health by promoting cell survival and mitigating damage. Piracetam, a GABAergic compound, enhances cerebral and nervous system resilience to hypoxia and modulates neuronal ion channel activity.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Citcopace P 500mg/800mg tablets has an undetermined safety profile. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Citcopace P 500mg/800mg tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Citcopace P 500mg/800mg tablets with breastfeeding are absent. Seek medical advice.
DrivingUNSAFE
Taking Citcopace P 500mg/800mg tablets might induce drowsiness or tremors, potentially impairing driving skills. Driving while using this medication may be unsafe due to these possible side effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when taking Citcopace P 500mg/800mg tablets, potentially requiring dosage modification. A physician's consultation is advised. Citcopace P 500mg/800mg tablets are contraindicated in individuals with severely compromised kidney function.
LiverSAFE IF PRESCRIBED
The use of Citcopace P 500mg/800mg tablets in patients with liver conditions is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Citcopace P 500mg/800mg Tablet :
Should you forget a Citcopace P 500mg/800mg Tablet dose, administer it immediately if feasible. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Citcopace P 500mg/800mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
